For research use only. Not for therapeutic Use.
Cipralisant (enantiomer)(Cat No.:I028434)is a selective antagonist of the histamine H3 receptor, a key regulator of neurotransmitter release in the central nervous system. This compound, being an enantiomer, is a mirror image of the original Cipralisant, and is studied for its potential to modulate histamine-driven pathways involved in cognitive function, sleep-wake regulation, and appetite control. By blocking H3 receptors, Cipralisant (enantiomer) may enhance neurotransmitter release, promoting alertness and improving cognitive performance. It is being explored for its therapeutic potential in treating conditions like Alzheimer’s disease, narcolepsy, and other cognitive disorders.
CAS Number | 223420-11-9 |
Synonyms | 5-[(1S,2S)-2-(5,5-dimethylhex-1-ynyl)cyclopropyl]-1H-imidazole |
Molecular Formula | C14H20N2 |
Purity | ≥95% |
IUPAC Name | 5-[(1S,2S)-2-(5,5-dimethylhex-1-ynyl)cyclopropyl]-1H-imidazole |
InChI | InChI=1S/C14H20N2/c1-14(2,3)7-5-4-6-11-8-12(11)13-9-15-10-16-13/h9-12H,5,7-8H2,1-3H3,(H,15,16)/t11-,12-/m0/s1 |
InChIKey | CVKJAXCQPFOAIN-RYUDHWBXSA-N |
SMILES | CC(C)(C)CCC#C[C@H]1C[C@@H]1C2=CN=CN2 |